fluoroquinolone

(redirected from Fluoroquinolones)
Also found in: Medical.
Related to Fluoroquinolones: ciprofloxacin

fluor·o·quin·o·lone

 (flo͝or′ə-kwĭn′ə-lōn′, flôr′-)
n.
Any of a group of broad-spectrum antibiotics that are fluorinated quinolones, the first of which was nalidixic acid.
Translations

fluoroquinolone

n fluoroquinolona
References in periodicals archive ?
It would be irresponsible to use these potent antibiotics and not take into account the fact that some reports of resistance to the fluoroquinolones has emerged," he argues.
In comparison with other available fluoroquinolones, trovafloxacin offered enhanced activity against anaerobic and gram-positive organisms, including Streptococcus pneumonia.
A certain class of antibiotics called fluoroquinolones has long been associated with serious tendon injuries.
The microbiology studies demonstrate JNJ-Q2's potent activity against a variety of diverse, clinically important gram positive and gram negative pathogens, including those resistant to other fluoroquinolones.
They should never be used for simple infections, like sinusitis or UTIs because fluoroquinolones are inappropriate and ineffective for those types of infections.
Antimicrobial drug susceptibility to therapeutic drugs (metronidazole and vancomycin) and to fluoroquinolones (moxifloxacin and levofloxacin) was determined by using the Etest method (breakpoints according to European Committee on Antimicrobial Susceptibility Testing guidelines).
Although researchers are still investigating exactly how fluoroquinolones cause tendon injuries, studies suggest that they can degrade tendon cells.
The FDA's ban on fluoroquinolones in poultry production may be insufficient to reduce resistant Campylobacter in poultry products.
Federal health officials have changed their recommendations for gonorrhea treatment due to resistance to antibiotics known as fluoroquinolones.
NICE, FRANCE -- Family practitioners prescribe penicillins most often, whereas surgeons prescribe fluoroquinolones more frequently than any other specialty.
Nitrofurantoin, first approved in 1953 for the treatment of urinary tract infection (UTI), has been overshadowed in the last several decades, first by trimethoprim-sulfamethoxazole (TMP-SMX), and more recently by fluoroquinolones.
He said that FDA's objective is to keep the germs vulnerable to enrofloxacin and other antibiotics in the class known as fluoroquinolones.